Go Pro

Linde (LIN) Financials

Linde logo
$467.80 -9.77 (-2.05%)
As of 12:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Linde

Annual Income Statements for Linde

This table shows Linde's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,500 1,247 4,381 2,285 2,501 3,826 4,147 6,199 6,565 6,898
Consolidated Net Income / (Loss)
1,538 1,308 4,405 2,381 2,626 3,961 4,281 6,341 6,737 7,058
Net Income / (Loss) Continuing Operations
1,538 1,308 4,288 2,272 2,622 3,956 4,281 6,341 6,737 7,058
Total Pre-Tax Income
2,048 2,287 5,049 2,927 3,384 5,099 5,543 7,988 8,569 8,897
Total Operating Income
2,247 2,444 5,247 2,933 3,322 4,984 5,369 8,024 8,635 8,923
Total Gross Profit
4,679 4,976 5,816 11,584 11,860 13,250 13,914 15,362 15,862 16,597
Total Revenue
10,534 11,358 14,836 28,228 27,243 30,793 33,364 32,854 33,005 33,986
Operating Revenue
10,534 11,358 14,836 28,228 27,243 30,793 33,364 32,854 33,005 33,986
Total Cost of Revenue
5,855 6,382 9,020 16,644 15,383 17,543 19,450 17,492 17,143 17,389
Operating Cost of Revenue
5,855 6,382 9,020 16,644 15,383 17,543 19,450 17,492 17,143 17,389
Total Operating Expenses
2,432 2,532 569 8,651 8,538 8,266 8,545 7,338 7,227 7,674
Selling, General & Admin Expense
1,145 1,207 1,629 3,457 3,193 3,189 3,107 3,295 3,337 3,433
Research & Development Expense
92 93 113 184 152 143 143 146 150 147
Depreciation Expense
1,122 1,184 1,830 4,675 4,626 4,635 4,204 3,816 3,780 3,763
Other Operating Expenses / (Income)
-23 -4.00 -3,312 -232 61 26 62 41 -185 58
Restructuring Charge
- - - - 506 273 1,029 40 145 273
Total Other Income / (Expense), net
-199 -157 -198 -6.00 62 115 174 -36 -66 -26
Interest Expense
190 161 202 38 115 77 63 200 256 255
Other Income / (Expense), net
-9.00 4.00 4.00 32 177 192 237 164 190 229
Income Tax Expense
551 1,026 817 769 847 1,262 1,434 1,814 2,002 1,989
Other Gains / (Losses), net
41 47 56 114 85 119 172 167 170 150
Net Income / (Loss) Attributable to Noncontrolling Interest
38 61 24 96 125 135 134 142 172 160
Basic Earnings per Share
$5.25 $4.36 $13.26 $4.22 $4.75 $7.40 - $12.70 $13.71 $14.69
Weighted Average Basic Shares Outstanding
285.68M 286.26M 330.40M 541.09M 526.74M 516.90M 499.74M 488.19M 478.77M 469.49M
Diluted Earnings per Share
$5.21 $4.32 $13.11 $4.19 $4.71 $7.33 $8.23 $12.59 $13.62 $14.61
Weighted Average Diluted Shares Outstanding
287.76M 289.11M 334.13M 545.17M 531.16M 521.88M 504.04M 492.29M 482.09M 472.20M
Weighted Average Basic & Diluted Shares Outstanding
- 286M 330.40M 532.96M 522.84M 507.74M 492.16M 481.58M 472.91M 463.39M
Cash Dividends to Common per Share
$3.00 $3.15 $3.30 $3.50 $3.85 $4.24 $4.68 $5.10 $5.56 $6.00

Quarterly Income Statements for Linde

This table shows Linde's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
1,543 1,627 1,663 1,550 1,725 1,673 1,766 1,929 1,530 1,857 1,928
Consolidated Net Income / (Loss)
1,576 1,665 1,700 1,603 1,769 1,707 1,806 1,972 1,573 1,900 1,972
Net Income / (Loss) Continuing Operations
1,576 1,665 1,700 1,603 1,769 1,707 1,806 1,972 1,573 1,900 1,972
Total Pre-Tax Income
1,996 2,080 2,163 2,063 2,263 2,180 2,346 2,360 2,011 2,431 2,546
Total Operating Income
2,028 2,095 2,184 2,086 2,270 2,184 2,354 2,367 2,018 2,439 2,554
Total Gross Profit
3,871 3,884 4,016 4,000 3,962 3,955 4,189 4,236 4,217 4,258 4,428
Total Revenue
8,302 8,100 8,267 8,356 8,282 8,112 8,495 8,615 8,764 8,781 9,289
Operating Revenue
8,302 8,100 8,267 8,356 8,282 8,112 8,495 8,615 8,764 8,781 9,289
Total Cost of Revenue
4,431 4,216 4,251 4,356 4,320 4,157 4,306 4,379 4,547 4,523 4,861
Operating Cost of Revenue
4,431 4,216 4,251 4,356 4,320 4,157 4,306 4,379 4,547 4,523 4,861
Total Operating Expenses
1,843 1,789 1,832 1,914 1,692 1,771 1,835 1,869 2,199 1,819 1,874
Selling, General & Admin Expense
832 860 840 823 814 786 870 897 880 893 891
Research & Development Expense
39 38 36 37 39 38 38 36 35 38 37
Depreciation Expense
949 949 958 960 913 910 942 961 950 951 963
Other Operating Expenses / (Income)
25 -58 -2.00 -51 -74 -18 -15 -14 105 -63 -17
Restructuring Charge
-2.00 0.00 0.00 145 - 55 0.00 -11 229 0.00 0.00
Total Other Income / (Expense), net
-32 -15 -21 -23 -7.00 -4.00 -8.00 -7.00 -7.00 -8.00 -8.00
Interest Expense
71 65 70 68 53 60 67 64 64 62 61
Other Income / (Expense), net
39 50 49 45 46 56 59 57 57 54 53
Income Tax Expense
459 463 508 498 533 511 573 424 481 571 610
Other Gains / (Losses), net
39 48 45 38 39 38 33 36 43 40 36
Net Income / (Loss) Attributable to Noncontrolling Interest
33 38 37 53 44 34 40 43 43 43 44
Basic Earnings per Share
- - - $3.24 - $3.53 $3.75 $4.11 - $4.00 $4.17
Weighted Average Basic Shares Outstanding
488.19M 481.95M 479.97M 477.66M 478.77M 473.30M 470.87M 468.80M 469.49M 464.05M 462.53M
Diluted Earnings per Share
$3.15 $3.35 $3.44 $3.22 $3.61 $3.51 $3.73 $4.09 $3.28 $3.98 $4.15
Weighted Average Diluted Shares Outstanding
492.29M 485.59M 483.18M 480.90M 482.09M 476.26M 473.57M 471.51M 472.20M 466.32M 464.52M
Weighted Average Basic & Diluted Shares Outstanding
481.58M 480.68M 477.50M 476.16M 472.91M 471.29M 468.91M 466.95M 463.39M 462.60M 460.98M

Annual Cash Flow Statements for Linde

This table details how cash moves in and out of Linde's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
723 -51 4,073 -1,752 1,054 -931 2,613 -772 186 6,973
Net Cash From Operating Activities
2,789 2,919 3,702 6,010 7,429 9,725 8,864 9,305 9,423 10,350
Net Cash From Continuing Operating Activities
2,789 3,041 3,654 6,119 7,429 9,725 8,864 9,389 9,405 17,248
Net Income / (Loss) Continuing Operations
1,538 1,308 4,288 2,272 2,622 3,956 4,281 6,341 6,737 13,956
Consolidated Net Income / (Loss)
1,538 1,186 4,396 2,374 2,622 3,826 4,281 6,199 6,737 13,956
Depreciation Expense
1,122 1,184 1,830 4,675 4,626 4,635 4,204 3,816 3,780 3,763
Non-Cash Adjustments To Reconcile Net Income
68 128 -2,646 -289 174 1,649 577 40 -41 254
Changes in Operating Assets and Liabilities, net
61 421 -186 -551 7.00 -380 -198 -666 -1,071 -725
Net Cash From Investing Activities
-1,407 -1,314 5,340 1,129 -2,986 -3,007 -3,088 -4,670 -4,644 -5,721
Net Cash From Continuing Investing Activities
-1,407 -1,314 5,363 1,189 -2,986 -3,007 -3,088 -4,670 -4,644 -5,721
Purchase of Property, Plant & Equipment
-1,465 -1,311 -1,883 -3,682 -3,400 -3,086 -3,173 -3,787 -4,497 -5,261
Acquisitions
- -33 -25 -225 -68 -88 -110 -953 -317 -412
Divestitures
58 30 5,908 5,096 482 167 195 70 170 42
Other Investing Activities, net
- - 1,363 - - - - 0.00 - -90
Net Cash From Financing Activities
-659 -1,656 -4,996 -8,992 -3,345 -7,588 -3,089 -5,400 -4,359 -4,554
Net Cash From Continuing Financing Activities
-659 -1,656 -4,998 -8,997 -3,345 -7,588 -3,089 -5,400 -4,359 -4,554
Repayment of Debt
-841 -874 -3,526 -4,843 -1,703 -1,791 -1,873 -1,735 -1,725 -2,313
Repurchase of Common Equity
-228 -12 -599 -2,658 -2,457 -4,612 -5,168 -3,958 -4,482 -4,601
Payment of Dividends
-856 -901 -1,166 -1,891 -2,028 -2,189 -2,344 -2,482 -2,655 -2,811
Issuance of Debt
1,127 11 216 323 2,796 954 6,260 2,742 4,472 5,148
Issuance of Common Equity
139 120 77 72 47 50 36 33 31 23
Cash Interest Paid
189 184 214 275 322 233 170 451 443 548

Quarterly Cash Flow Statements for Linde

This table details how cash moves in and out of Linde's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
770 184 3,202 -2,917 -283 444 -508 4,956 2,081 -1,097 939
Net Cash From Operating Activities
2,727 1,954 1,929 2,731 2,809 2,161 2,211 2,948 3,030 2,240 2,271
Net Cash From Continuing Operating Activities
2,836 1,989 5,222 -687 2,937 2,152 2,233 8,303 4,560 2,232 2,291
Net Income / (Loss) Continuing Operations
1,685 1,665 5,028 -1,815 1,897 1,707 1,806 7,340 3,103 1,900 1,972
Consolidated Net Income / (Loss)
1,685 1,665 5,028 -1,815 1,897 1,707 1,806 7,340 3,103 1,900 1,972
Depreciation Expense
949 949 958 960 913 910 942 961 950 951 963
Non-Cash Adjustments To Reconcile Net Income
-29 -17 -169 48 115 60 14 12 168 -3.00 -13
Changes in Operating Assets and Liabilities, net
231 -608 -595 120 12 -525 -529 -10 339 -616 -631
Net Cash From Investing Activities
-1,226 -1,041 -1,270 -957 -1,376 -1,369 -1,457 -1,434 -1,461 -1,384 -1,658
Net Cash From Continuing Investing Activities
-1,226 -1,041 -1,270 -957 -1,376 -1,369 -1,457 -1,434 -1,461 -1,384 -1,658
Purchase of Property, Plant & Equipment
-1,151 -1,048 -1,133 -1,066 -1,250 -1,270 -1,257 -1,276 -1,458 -1,342 -1,438
Acquisitions
-111 0.00 -152 -23 -142 -112 -158 -123 -19 -153 -232
Divestitures
36 7.00 15 132 16 13 11 7.00 11 112 11
Other Investing Activities, net
- - - - - 0.00 - -42 5.00 -1.00 1.00
Net Cash From Financing Activities
-780 -668 -808 -1,273 -1,610 -388 -1,366 -1,782 -1,018 -1,968 321
Net Cash From Continuing Financing Activities
-780 -668 -808 -1,273 -1,610 -388 -1,366 -1,782 -1,018 -1,968 321
Repayment of Debt
242 -799 -1,080 41 744 -1,085 -534 323 -1,017 -820 -96
Repurchase of Common Equity
-1,033 -1,041 -1,440 -667 -1,334 -1,111 -1,111 -989 -1,390 -807 -871
Payment of Dividends
-616 -669 -665 -662 -659 -708 -704 -701 -698 -741 -738
Issuance of Debt
619 1,825 2,372 8.00 -364 2,505 979 -420 2,084 397 2,007
Issuance of Common Equity
8.00 16 5.00 7.00 3.00 11 4.00 5.00 3.00 3.00 19
Other Net Changes in Cash
- -61 - - - 40 104 - - 15 5.00

Annual Balance Sheets for Linde

This table presents Linde's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
20,436 93,386 86,612 88,229 81,605 79,658 80,811 80,147 86,817
Total Current Assets
3,285 17,272 10,352 10,924 10,159 13,047 12,620 12,945 13,325
Cash & Equivalents
617 4,466 2,700 3,754 2,823 5,436 4,664 4,850 5,056
Accounts Receivable
1,710 4,297 4,322 4,167 4,499 4,559 4,718 4,622 4,966
Inventories, net
614 1,651 1,697 1,729 1,733 1,978 2,115 1,946 2,055
Other Current Assets
344 1,360 1,633 1,274 1,104 1,074 1,123 1,527 1,248
Plant, Property, & Equipment, net
11,825 29,717 0.00 0.00 26,003 23,548 24,552 24,775 28,260
Total Noncurrent Assets
5,326 46,397 76,260 77,305 45,443 43,063 43,639 42,427 45,232
Goodwill
3,233 26,874 27,019 28,201 27,038 25,817 26,751 25,937 27,927
Intangible Assets
785 16,223 16,137 16,184 13,802 12,420 12,399 11,330 11,871
Other Noncurrent Operating Assets
581 1,462 31,077 30,859 1,984 2,476 2,299 3,030 5,434
Total Liabilities & Shareholders' Equity
20,436 93,386 86,612 88,229 81,605 79,658 80,811 80,147 86,817
Total Liabilities
13,914 36,290 34,977 38,647 36,164 38,271 39,716 40,659 47,076
Total Current Liabilities
3,307 12,956 12,160 13,740 13,643 16,479 15,717 14,544 15,198
Short-Term Debt
1,217 3,008 3,263 4,002 2,872 5,716 5,976 6,280 6,306
Accounts Payable
922 3,219 3,266 3,095 3,503 2,995 3,020 2,507 2,810
Current Deferred Revenue
0.00 1,546 1,758 1,769 - 3,073 1,901 1,194 1,231
Other Current Liabilities
926 3,758 3,503 4,332 6,839 4,082 4,156 3,926 4,851
Total Noncurrent Liabilities
10,607 23,334 22,817 24,907 22,521 21,792 23,999 26,115 31,878
Long-Term Debt
7,783 12,288 10,693 12,152 11,335 12,198 13,397 15,343 20,683
Other Noncurrent Operating Liabilities
1,588 3,435 4,888 5,519 4,188 2,795 3,804 4,015 11,195
Redeemable Noncontrolling Interest
11 16 113 13 13 13 13 13 13
Total Equity & Noncontrolling Interests
6,511 57,080 51,522 49,569 45,428 41,374 41,082 39,475 39,728
Total Preferred & Common Equity
6,018 51,596 49,074 47,317 44,035 40,028 39,720 38,092 38,245
Total Common Equity
6,018 51,596 49,074 47,317 44,035 40,028 39,720 38,092 38,245
Common Stock
4,088 40,152 40,202 40,203 40,181 40,006 39,813 39,604 39,431
Retained Earnings
13,224 16,529 16,842 17,178 18,710 20,541 8,845 12,634 16,608
Treasury Stock
-7,196 -629 -3,156 -5,374 -9,808 -14,737 -3,133 -7,252 -11,561
Accumulated Other Comprehensive Income / (Loss)
-4,098 -4,456 -4,814 -4,690 -5,048 -5,782 -5,805 -6,894 -6,233
Noncontrolling Interest
493 5,484 2,448 2,252 1,393 1,346 1,362 1,383 1,483

Quarterly Balance Sheets for Linde

This table presents Linde's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
77,827 80,811 80,347 80,215 82,546 80,147 82,704 86,078 85,993 86,315 88,349
Total Current Assets
11,737 12,620 13,102 12,843 13,460 12,945 13,597 13,627 13,331 12,751 14,176
Cash & Equivalents
3,894 4,664 4,848 4,626 5,187 4,850 5,294 4,786 4,509 3,959 4,898
Accounts Receivable
4,692 4,718 5,009 5,001 4,871 4,622 4,950 5,230 5,331 5,321 5,632
Inventories, net
2,078 2,115 2,100 2,094 2,087 1,946 1,984 2,122 2,128 2,079 2,122
Other Current Assets
1,073 1,123 1,145 1,122 1,315 1,527 1,369 1,489 1,363 1,392 1,524
Plant, Property, & Equipment, net
23,624 24,552 24,418 24,575 25,124 24,775 25,710 26,928 27,535 28,564 29,170
Total Noncurrent Assets
42,466 43,639 42,827 42,797 43,962 42,427 43,397 45,523 45,127 45,000 45,003
Goodwill
25,955 26,751 26,289 26,365 27,108 25,937 26,507 27,812 27,828 27,882 27,927
Intangible Assets
12,092 12,399 12,001 11,851 12,113 11,330 11,561 12,082 11,931 11,673 11,564
Other Noncurrent Operating Assets
4,419 2,299 4,537 4,581 4,741 3,030 5,329 5,629 5,368 5,445 5,512
Total Liabilities & Shareholders' Equity
77,827 80,811 80,347 80,215 82,546 80,147 82,704 86,078 85,993 86,315 88,349
Total Liabilities
37,589 39,716 40,118 40,664 41,943 40,659 43,241 46,092 45,907 46,223 47,719
Total Current Liabilities
14,162 15,717 14,389 13,504 14,049 14,544 14,485 14,714 16,192 15,391 16,127
Short-Term Debt
4,771 5,976 5,092 4,587 4,787 6,280 6,289 6,219 7,333 6,458 7,335
Accounts Payable
2,750 3,020 2,885 2,859 2,845 2,507 2,446 2,593 2,646 2,659 2,837
Current Deferred Revenue
- 1,901 1,827 1,767 1,727 1,194 1,196 1,261 1,279 1,168 1,128
Other Current Liabilities
6,641 4,156 4,585 4,291 4,690 3,926 4,554 4,641 4,934 5,106 4,827
Total Noncurrent Liabilities
23,427 23,999 25,729 27,160 27,894 26,115 28,756 31,378 29,715 30,832 31,592
Long-Term Debt
13,232 13,397 15,227 16,931 17,475 15,343 17,608 19,701 18,592 19,859 20,678
Other Noncurrent Operating Liabilities
10,195 3,804 10,502 10,229 10,419 4,015 11,148 11,677 11,123 10,973 10,914
Redeemable Noncontrolling Interest
13 13 13 13 13 13 13 13 13 13 13
Total Equity & Noncontrolling Interests
40,225 41,082 40,216 39,538 40,590 39,475 39,450 39,973 40,073 40,079 40,617
Total Preferred & Common Equity
38,898 39,720 38,829 38,179 39,173 38,092 38,032 38,515 38,616 38,566 39,081
Total Common Equity
38,898 39,720 38,829 38,179 39,173 38,092 38,032 38,515 38,616 38,566 39,081
Common Stock
39,803 39,813 39,571 39,561 39,574 39,604 39,409 39,412 39,406 39,178 39,131
Retained Earnings
7,940 8,845 9,708 10,721 11,585 12,634 13,545 14,595 15,796 17,639 18,804
Treasury Stock
-2,169 -3,133 -3,922 -5,309 -5,927 -7,252 -8,154 -9,242 -10,177 -12,104 -12,928
Accumulated Other Comprehensive Income / (Loss)
-6,676 -5,805 -6,528 -6,794 -6,059 -6,894 -6,768 -6,250 -6,409 -6,147 -5,926
Noncontrolling Interest
1,327 1,362 1,387 1,359 1,417 1,383 1,418 1,458 1,457 1,513 1,536

Annual Metrics And Ratios for Linde

This table displays calculated financial ratios and metrics derived from Linde's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 7.82% 30.62% 90.27% -3.49% 13.03% 8.35% -1.53% 0.46% 2.97%
EBITDA Growth
0.00% 8.10% 105.09% 2.73% 6.18% 20.75% -0.01% 22.36% 5.01% 2.46%
EBIT Growth
0.00% 9.38% 114.50% -43.53% 18.01% 47.93% 8.31% 46.06% 7.78% 3.71%
NOPAT Growth
0.00% -17.95% 226.36% -50.83% 15.17% 50.59% 6.12% 55.82% 6.70% 4.69%
Net Income Growth
0.00% -14.95% 236.77% -45.95% 10.29% 50.84% 8.08% 48.12% 6.25% 4.76%
EPS Growth
0.00% -17.08% 203.47% -68.04% 12.41% 55.63% 12.28% 52.98% 8.18% 7.27%
Operating Cash Flow Growth
0.00% 4.66% 26.82% 62.34% 23.61% 30.91% -8.85% 4.98% 1.27% 9.84%
Free Cash Flow Firm Growth
0.00% 0.00% -233.44% 106.21% 29.25% 175.68% -29.52% -38.50% 48.69% -77.05%
Invested Capital Growth
0.00% 0.00% 332.77% -0.81% -1.55% -9.54% -4.96% 4.07% 0.96% 10.21%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 4.75% 0.71% 3.45% -1.18% 1.24% -0.06% 1.44%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -25.92% 5.52% 2.66% 1.87% 2.69% 1.72% -1.56%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -46.43% 12.73% 6.39% 6.84% 4.09% 2.90% -2.57%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -52.34% 12.74% 6.35% 8.21% 4.32% 2.70% -2.81%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -50.36% 11.27% 6.79% 7.67% 3.51% 2.95% -2.70%
EPS Q/Q Growth
0.00% 0.00% 0.00% -63.69% 12.14% 7.95% 8.72% 4.14% 3.50% -2.21%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 12.61% 4.38% 8.95% -11.38% 7.29% 0.88% 2.18%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 7.94% 36.07% -38.92% 93.60% 95.98% -57.62%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -2.09% -2.08% -6.16% 1.97% -1.35% -6.15% -3.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
44.42% 43.81% 39.20% 41.04% 43.53% 43.03% 41.70% 46.76% 48.06% 48.83%
EBITDA Margin
31.90% 31.98% 50.21% 27.11% 29.82% 31.86% 29.40% 36.54% 38.19% 38.00%
Operating Margin
21.33% 21.52% 35.37% 10.39% 12.19% 16.19% 16.09% 24.42% 26.16% 26.25%
EBIT Margin
21.25% 21.55% 35.39% 10.50% 12.84% 16.81% 16.80% 24.92% 26.74% 26.93%
Profit (Net Income) Margin
14.60% 11.52% 29.69% 8.43% 9.64% 12.86% 12.83% 19.30% 20.41% 20.77%
Tax Burden Percent
75.10% 57.19% 87.25% 81.35% 77.60% 77.68% 77.23% 79.38% 78.62% 79.33%
Interest Burden Percent
91.51% 93.42% 96.15% 98.72% 96.71% 98.51% 98.88% 97.56% 97.10% 97.21%
Effective Tax Rate
26.90% 44.86% 16.18% 26.27% 25.03% 24.75% 25.87% 22.71% 23.36% 22.36%
Return on Invested Capital (ROIC)
0.00% 19.01% 11.64% 3.54% 4.12% 6.57% 7.53% 11.80% 12.28% 12.18%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 17.98% 11.76% 6.78% 5.51% 8.78% 10.72% 13.03% 13.16% 12.93%
Return on Net Nonoperating Assets (RNNOA)
0.00% 21.10% 2.20% 0.84% 1.07% 1.76% 2.33% 3.58% 4.44% 5.64%
Return on Equity (ROE)
0.00% 40.11% 13.85% 4.38% 5.19% 8.34% 9.86% 15.38% 16.72% 17.82%
Cash Return on Invested Capital (CROIC)
0.00% -180.99% -113.28% 4.35% 5.69% 16.59% 12.62% 7.81% 11.32% 2.46%
Operating Return on Assets (OROA)
0.00% 11.98% 9.23% 3.29% 4.00% 6.10% 6.95% 10.21% 10.97% 10.96%
Return on Assets (ROA)
0.00% 6.40% 7.74% 2.65% 3.00% 4.66% 5.31% 7.90% 8.37% 8.45%
Return on Common Equity (ROCE)
0.00% 37.01% 12.54% 4.05% 4.94% 8.01% 9.55% 14.87% 16.15% 17.17%
Return on Equity Simple (ROE_SIMPLE)
0.00% 21.73% 8.54% 4.85% 5.55% 9.00% 10.70% 15.96% 17.69% 0.00%
Net Operating Profit after Tax (NOPAT)
1,642 1,348 4,398 2,162 2,491 3,750 3,980 6,202 6,618 6,928
NOPAT Margin
15.59% 11.86% 29.64% 7.66% 9.14% 12.18% 11.93% 18.88% 20.05% 20.39%
Net Nonoperating Expense Percent (NNEP)
0.00% 1.03% -0.12% -3.24% -1.38% -2.20% -3.19% -1.23% -0.88% -0.75%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 6.71% 10.26% 10.83% 10.38%
Cost of Revenue to Revenue
55.58% 56.19% 60.80% 58.96% 56.47% 56.97% 58.30% 53.24% 51.94% 51.17%
SG&A Expenses to Revenue
10.87% 10.63% 10.98% 12.25% 11.72% 10.36% 9.31% 10.03% 10.11% 10.10%
R&D to Revenue
0.87% 0.82% 0.76% 0.65% 0.56% 0.46% 0.43% 0.44% 0.45% 0.43%
Operating Expenses to Revenue
23.09% 22.29% 3.84% 30.65% 31.34% 26.84% 25.61% 22.34% 21.90% 22.58%
Earnings before Interest and Taxes (EBIT)
2,238 2,448 5,251 2,965 3,499 5,176 5,606 8,188 8,825 9,152
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,360 3,632 7,449 7,652 8,125 9,811 9,810 12,004 12,605 12,915
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.54 2.19 2.80 3.92 3.93 5.03 5.41 5.49
Price to Tangible Book Value (P/TBV)
0.00 0.00 9.35 18.19 45.16 53.99 87.74 350.35 249.76 0.00
Price to Revenue (P/Rev)
0.00 0.00 5.35 3.81 4.86 5.60 4.71 6.08 6.24 6.17
Price to Earnings (P/E)
0.00 0.00 18.13 47.11 52.94 45.08 37.89 32.21 31.39 30.42
Dividend Yield
2.03% 0.00% 1.14% 2.16% 1.53% 1.26% 1.47% 1.26% 1.33% 1.41%
Earnings Yield
0.00% 35,488.52% 5.52% 2.12% 1.89% 2.22% 2.64% 3.10% 3.19% 3.29%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.58 1.53 1.96 2.42 3.37 3.27 3.98 4.10 3.88
Enterprise Value to Revenue (EV/Rev)
0.00 0.72 6.33 4.23 5.32 5.93 5.05 6.50 6.73 6.80
Enterprise Value to EBITDA (EV/EBITDA)
0.00 2.25 12.61 15.61 17.85 18.62 17.19 17.79 17.62 17.91
Enterprise Value to EBIT (EV/EBIT)
0.00 3.33 17.89 40.29 41.44 35.29 30.08 26.09 25.17 25.27
Enterprise Value to NOPAT (EV/NOPAT)
0.00 6.06 21.36 55.24 58.23 48.70 42.37 34.44 33.56 33.38
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 2.80 25.37 19.87 19.52 18.78 19.02 22.95 23.57 22.34
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 44.97 42.23 19.30 25.28 52.06 36.41 165.17
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 1.38 0.27 0.27 0.33 0.31 0.43 0.47 0.55 0.68
Long-Term Debt to Equity
0.00 1.19 0.22 0.21 0.25 0.25 0.29 0.33 0.39 0.52
Financial Leverage
0.00 1.17 0.19 0.12 0.19 0.20 0.22 0.27 0.34 0.44
Leverage Ratio
0.00 3.13 1.79 1.66 1.73 1.79 1.86 1.95 2.00 2.11
Compound Leverage Factor
0.00 2.93 1.72 1.63 1.67 1.76 1.84 1.90 1.94 2.05
Debt to Total Capital
0.00% 57.98% 21.13% 21.28% 24.57% 23.82% 30.21% 32.04% 35.38% 40.45%
Short-Term Debt to Total Capital
0.00% 7.84% 4.16% 4.97% 6.09% 4.81% 9.64% 9.88% 10.28% 9.45%
Long-Term Debt to Total Capital
0.00% 50.14% 16.97% 16.30% 18.49% 19.00% 20.57% 22.16% 25.11% 31.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 3.25% 7.60% 3.90% 3.45% 2.36% 2.29% 2.27% 2.28% 2.24%
Common Equity to Total Capital
0.00% 38.77% 71.27% 74.82% 71.98% 73.82% 67.50% 65.69% 62.33% 57.31%
Debt to EBITDA
0.00 2.48 2.05 1.82 1.99 1.45 1.83 1.61 1.72 2.09
Net Debt to EBITDA
0.00 2.11 1.21 1.21 1.27 0.89 1.03 1.04 1.16 1.54
Long-Term Debt to EBITDA
0.00 2.14 1.65 1.40 1.50 1.16 1.24 1.12 1.22 1.60
Debt to NOPAT
0.00 6.68 3.48 6.45 6.49 3.79 4.50 3.12 3.27 3.90
Net Debt to NOPAT
0.00 5.68 2.04 4.27 4.15 2.34 2.54 2.02 2.21 2.87
Long-Term Debt to NOPAT
0.00 5.78 2.79 4.94 4.88 3.02 3.06 2.16 2.32 2.99
Altman Z-Score
0.00 1.86 1.96 2.53 2.73 3.72 3.42 3.87 4.01 3.66
Noncontrolling Interest Sharing Ratio
0.00% 7.73% 9.44% 7.41% 4.77% 3.86% 3.18% 3.31% 3.44% 3.65%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 0.99 1.33 0.85 0.80 0.74 0.79 0.80 0.89 0.88
Quick Ratio
0.00 0.70 0.68 0.58 0.58 0.54 0.61 0.60 0.65 0.66
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -12,830 -42,782 2,656 3,434 9,465 6,671 4,103 6,101 1,400
Operating Cash Flow to CapEx
190.38% 222.65% 196.60% 163.23% 218.50% 315.13% 279.36% 245.71% 209.54% 196.73%
Free Cash Flow to Firm to Interest Expense
0.00 -79.69 -211.79 69.91 29.86 122.93 105.89 20.51 23.83 5.49
Operating Cash Flow to Interest Expense
14.68 18.13 18.33 158.16 64.60 126.30 140.70 46.53 36.81 40.59
Operating Cash Flow Less CapEx to Interest Expense
6.97 9.99 9.01 61.26 35.03 86.22 90.33 27.59 19.24 19.96
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.56 0.26 0.31 0.31 0.36 0.41 0.41 0.41 0.41
Accounts Receivable Turnover
0.00 6.64 4.94 6.55 6.42 7.11 7.37 7.08 7.07 7.09
Inventory Turnover
0.00 10.39 7.96 9.94 8.98 10.13 10.48 8.55 8.44 8.69
Fixed Asset Turnover
0.00 0.96 0.71 0.00 0.00 0.00 1.35 1.37 1.34 1.28
Accounts Payable Turnover
0.00 6.92 4.36 5.13 4.84 5.32 5.99 5.82 6.20 6.54
Days Sales Outstanding (DSO)
0.00 54.95 73.89 55.72 56.87 51.36 49.55 51.53 51.65 51.49
Days Inventory Outstanding (DIO)
0.00 35.12 45.83 36.71 40.65 36.02 34.82 42.70 43.23 41.99
Days Payable Outstanding (DPO)
0.00 52.73 83.78 71.11 75.47 68.64 60.97 62.76 58.84 55.80
Cash Conversion Cycle (CCC)
0.00 37.34 35.94 21.33 22.05 18.74 23.40 31.48 36.04 37.67
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 14,178 61,358 60,864 59,921 54,206 51,515 53,614 54,131 59,659
Invested Capital Turnover
0.00 1.60 0.39 0.46 0.45 0.54 0.63 0.63 0.61 0.60
Increase / (Decrease) in Invested Capital
0.00 14,178 47,180 -494 -943 -5,715 -2,691 2,099 517 5,528
Enterprise Value (EV)
0.00 8,164 93,920 119,447 145,014 182,653 168,627 213,594 222,092 231,266
Market Capitalization
0.00 3.51 79,428 107,657 132,410 172,482 157,140 199,700 206,053 209,852
Book Value per Share
$0.00 $240,720.00 $93.63 $91.36 $90.15 $85.91 $80.97 $81.92 $80.00 $81.90
Tangible Book Value per Share
$0.00 $80,000.00 $15.42 $11.02 $5.59 $6.23 $3.62 $1.18 $1.73 ($3.33)
Total Capital
0.00 15,522 72,392 65,591 65,736 59,648 59,301 60,468 61,111 66,730
Total Debt
0.00 9,000 15,296 13,956 16,154 14,207 17,914 19,373 21,623 26,989
Total Long-Term Debt
0.00 7,783 12,288 10,693 12,152 11,335 12,198 13,397 15,343 20,683
Net Debt
0.00 7,656 8,992 9,229 10,339 8,765 10,128 12,519 14,643 19,918
Capital Expenditures (CapEx)
1,465 1,311 1,883 3,682 3,400 3,086 3,173 3,787 4,497 5,261
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 578 2,858 -1,245 -2,568 -3,435 -3,152 -1,785 -169 -623
Debt-free Net Working Capital (DFNWC)
0.00 1,195 7,324 1,455 1,186 -612 2,284 2,879 4,681 4,433
Net Working Capital (NWC)
0.00 -22 4,316 -1,808 -2,816 -3,484 -3,432 -3,097 -1,599 -1,873
Net Nonoperating Expense (NNE)
104 40 -7.04 -219 -135 -211 -301 -139 -119 -130
Net Nonoperating Obligations (NNO)
0.00 7,656 4,262 9,229 10,339 8,765 10,128 12,519 14,643 19,918
Total Depreciation and Amortization (D&A)
1,122 1,184 2,198 4,687 4,626 4,635 4,204 3,816 3,780 3,763
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 5.09% 19.26% -4.41% -9.43% -11.16% -9.45% -5.43% -0.51% -1.83%
Debt-free Net Working Capital to Revenue
0.00% 10.52% 49.37% 5.15% 4.35% -1.99% 6.85% 8.76% 14.18% 13.04%
Net Working Capital to Revenue
0.00% -0.19% 29.09% -6.41% -10.34% -11.31% -10.29% -9.43% -4.84% -5.51%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $13.26 $4.22 $4.75 $7.40 $8.30 $12.70 $0.00 $14.69
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 330.40M 541.09M 526.74M 516.90M 499.74M 488.19M 478.77M 469.49M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $13.11 $4.19 $4.71 $7.33 $8.23 $12.59 $13.62 $14.61
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 334.13M 545.17M 531.16M 521.88M 504.04M 492.29M 482.09M 472.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 544.91M 532.96M 522.84M 507.74M 492.16M 481.58M 472.91M 463.39M
Normalized Net Operating Profit after Tax (NOPAT)
1,713 1,376 4,657 2,580 2,870 3,956 4,743 6,233 6,729 7,140
Normalized NOPAT Margin
16.26% 12.12% 31.39% 9.14% 10.53% 12.85% 14.22% 18.97% 20.39% 21.01%
Pre Tax Income Margin
19.44% 20.14% 34.03% 10.37% 12.42% 16.56% 16.61% 24.31% 25.96% 26.18%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
11.78 15.21 26.00 78.03 30.43 67.22 88.98 40.94 34.47 35.89
NOPAT to Interest Expense
8.64 8.37 21.77 56.91 21.66 48.71 63.17 31.01 25.85 27.17
EBIT Less CapEx to Interest Expense
4.07 7.06 16.67 -18.87 0.86 27.14 38.62 22.01 16.91 15.26
NOPAT Less CapEx to Interest Expense
0.93 0.23 12.45 -39.99 -7.91 8.63 12.81 12.07 8.28 6.54
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
55.66% 68.88% 26.47% 79.42% 77.23% 55.26% 54.75% 39.14% 39.41% 39.83%
Augmented Payout Ratio
70.48% 69.80% 40.07% 191.05% 170.79% 171.70% 175.47% 101.56% 105.94% 105.02%

Quarterly Metrics And Ratios for Linde

This table displays calculated financial ratios and metrics derived from Linde's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 462,599,539.00 460,980,163.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 462,599,539.00 460,980,163.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 4.01 4.18
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.10% -1.14% 0.77% 2.46% -0.24% 0.15% 2.76% 3.10% 5.82% 8.25% 9.35%
EBITDA Growth
11.66% 5.74% 5.80% 1.48% 7.06% 1.81% 5.14% 9.51% -6.32% 9.33% 6.41%
EBIT Growth
18.45% 8.44% 8.61% 2.11% 12.05% 4.43% 8.06% 13.75% -10.41% 11.29% 8.04%
NOPAT Growth
19.66% 8.23% 6.34% 1.19% 11.12% 2.66% 6.46% 22.71% -11.53% 11.61% 9.16%
Net Income Growth
15.80% 7.28% 5.46% 0.12% 12.25% 2.52% 6.24% 23.02% -11.08% 11.31% 9.19%
EPS Growth
18.87% 9.48% 7.84% 0.94% 14.60% 4.78% 8.43% 27.02% -9.14% 13.39% 11.26%
Operating Cash Flow Growth
30.17% 2.41% -10.28% 8.37% 3.01% 10.59% 14.62% 7.95% 7.87% 3.66% 2.71%
Free Cash Flow Firm Growth
-113.45% -60.54% 259.64% 22.71% 326.73% -164.27% -575.80% -7.65% -427.71% -262.84% 76.43%
Invested Capital Growth
4.07% 1.00% 1.92% 6.13% 0.96% 4.25% 8.29% 6.63% 10.21% 7.55% 4.29%
Revenue Q/Q Growth
1.80% -2.43% 2.06% 1.08% -0.89% -2.05% 4.72% 1.41% 1.73% 0.19% 5.79%
EBITDA Q/Q Growth
-0.98% 2.59% 3.14% -3.13% 4.46% -2.45% 6.51% 0.89% -10.64% 13.85% 3.66%
EBIT Q/Q Growth
-0.96% 3.77% 4.10% -4.57% 8.68% -3.28% 7.72% 0.46% -14.40% 20.14% 4.57%
NOPAT Q/Q Growth
-0.14% 4.29% 2.60% -5.30% 9.66% -3.65% 6.40% 9.15% -20.93% 21.55% 4.07%
Net Income Q/Q Growth
-1.56% 5.65% 2.10% -5.71% 10.36% -3.50% 5.80% 9.19% -20.23% 20.79% 3.79%
EPS Q/Q Growth
-1.25% 6.35% 2.69% -6.40% 12.11% -2.77% 6.27% 9.65% -19.80% 21.34% 4.27%
Operating Cash Flow Q/Q Growth
8.21% -28.35% -1.28% 41.58% 2.86% -23.07% 2.31% 33.33% 2.78% -26.07% 1.38%
Free Cash Flow Firm Q/Q Growth
76.25% 300.92% -43.59% -387.09% 169.68% -156.96% -317.61% 35.05% -112.12% 36.94% 72.88%
Invested Capital Q/Q Growth
-1.35% 3.89% 1.33% 2.19% -6.15% 7.27% 5.26% 0.63% -3.00% 4.68% 2.07%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
46.63% 47.95% 48.58% 47.87% 47.84% 48.75% 49.31% 49.17% 48.12% 48.49% 47.67%
EBITDA Margin
36.33% 38.20% 38.60% 36.99% 38.99% 38.83% 39.49% 39.29% 34.52% 39.22% 38.43%
Operating Margin
24.43% 25.86% 26.42% 24.96% 27.41% 26.92% 27.71% 27.48% 23.03% 27.78% 27.49%
EBIT Margin
24.90% 26.48% 27.01% 25.50% 27.96% 27.61% 28.40% 28.14% 23.68% 28.39% 28.07%
Profit (Net Income) Margin
18.98% 20.56% 20.56% 19.18% 21.36% 21.04% 21.26% 22.89% 17.95% 21.64% 21.23%
Tax Burden Percent
78.96% 80.05% 78.59% 77.70% 78.17% 78.30% 76.98% 83.56% 78.22% 78.16% 77.45%
Interest Burden Percent
96.57% 96.97% 96.87% 96.81% 97.71% 97.32% 97.22% 97.36% 96.92% 97.51% 97.66%
Effective Tax Rate
23.00% 22.26% 23.49% 24.14% 23.55% 23.44% 24.42% 17.97% 23.92% 23.49% 23.96%
Return on Invested Capital (ROIC)
11.76% 11.88% 11.87% 11.17% 12.84% 11.96% 11.84% 12.67% 10.46% 12.22% 11.87%
ROIC Less NNEP Spread (ROIC-NNEP)
11.88% 12.13% 12.05% 11.30% 13.08% 12.17% 11.99% 12.83% 10.68% 12.39% 12.01%
Return on Net Nonoperating Assets (RNNOA)
3.26% 4.36% 4.63% 4.36% 4.41% 5.20% 5.73% 6.12% 4.66% 6.38% 6.59%
Return on Equity (ROE)
15.02% 16.24% 16.50% 15.52% 17.25% 17.17% 17.57% 18.79% 15.12% 18.60% 18.46%
Cash Return on Invested Capital (CROIC)
7.81% 10.42% 9.59% 5.56% 11.32% 7.55% 3.56% 5.54% 2.46% 4.54% 7.46%
Operating Return on Assets (OROA)
10.19% 10.80% 11.16% 10.50% 11.47% 11.18% 11.36% 11.19% 9.64% 11.64% 11.41%
Return on Assets (ROA)
7.77% 8.38% 8.49% 7.90% 8.76% 8.52% 8.50% 9.10% 7.31% 8.87% 8.63%
Return on Common Equity (ROCE)
14.52% 15.69% 15.94% 14.99% 16.65% 16.56% 16.95% 18.12% 14.57% 17.91% 17.77%
Return on Equity Simple (ROE_SIMPLE)
0.00% 16.62% 17.14% 16.71% 0.00% 17.82% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,562 1,629 1,671 1,582 1,735 1,672 1,779 1,942 1,535 1,866 1,942
NOPAT Margin
18.81% 20.11% 20.21% 18.94% 20.95% 20.61% 20.94% 22.54% 17.52% 21.25% 20.91%
Net Nonoperating Expense Percent (NNEP)
-0.13% -0.25% -0.19% -0.13% -0.25% -0.21% -0.14% -0.16% -0.22% -0.17% -0.14%
Return On Investment Capital (ROIC_SIMPLE)
2.58% - - - 2.84% 2.64% 2.70% 2.94% 2.30% 2.81% 2.83%
Cost of Revenue to Revenue
53.37% 52.05% 51.42% 52.13% 52.16% 51.25% 50.69% 50.83% 51.88% 51.51% 52.33%
SG&A Expenses to Revenue
10.02% 10.62% 10.16% 9.85% 9.83% 9.69% 10.24% 10.41% 10.04% 10.17% 9.59%
R&D to Revenue
0.47% 0.47% 0.44% 0.44% 0.47% 0.47% 0.45% 0.42% 0.40% 0.43% 0.40%
Operating Expenses to Revenue
22.20% 22.09% 22.16% 22.91% 20.43% 21.83% 21.60% 21.69% 25.09% 20.72% 20.17%
Earnings before Interest and Taxes (EBIT)
2,067 2,145 2,233 2,131 2,316 2,240 2,413 2,424 2,075 2,493 2,607
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,016 3,094 3,191 3,091 3,229 3,150 3,355 3,385 3,025 3,444 3,570
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.03 5.89 5.66 5.99 5.41 6.03 6.00 6.05 5.49 6.33 6.54
Price to Tangible Book Value (P/TBV)
350.35 423.97 0.00 0.00 249.76 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
6.08 6.98 6.58 7.11 6.24 6.94 6.95 6.98 6.17 7.04 7.20
Price to Earnings (P/E)
32.21 36.22 33.76 36.77 31.39 34.66 34.39 32.96 30.42 34.45 35.26
Dividend Yield
1.26% 1.12% 1.21% 1.14% 1.33% 1.22% 1.23% 1.24% 1.41% 1.23% 1.19%
Earnings Yield
3.10% 2.76% 2.96% 2.72% 3.19% 2.88% 2.91% 3.03% 3.29% 2.90% 2.84%
Enterprise Value to Invested Capital (EV/IC)
3.98 4.41 4.15 4.39 4.10 4.29 4.15 4.17 3.88 4.29 4.39
Enterprise Value to Revenue (EV/Rev)
6.50 7.49 7.14 7.67 6.73 7.55 7.63 7.66 6.80 7.73 7.90
Enterprise Value to EBITDA (EV/EBITDA)
17.79 20.16 18.97 20.43 17.62 19.68 19.77 19.56 17.91 20.28 20.86
Enterprise Value to EBIT (EV/EBIT)
26.09 29.37 27.45 29.52 25.17 27.94 27.86 27.32 25.27 28.48 29.18
Enterprise Value to NOPAT (EV/NOPAT)
34.44 38.79 36.46 39.29 33.56 37.41 37.45 36.01 33.38 37.61 38.44
Enterprise Value to Operating Cash Flow (EV/OCF)
22.95 26.24 25.65 27.11 23.57 25.88 25.58 25.34 22.34 25.69 26.70
Enterprise Value to Free Cash Flow (EV/FCFF)
52.06 42.48 43.67 81.34 36.41 58.02 121.19 77.68 165.17 97.83 60.10
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.47 0.51 0.54 0.55 0.55 0.61 0.65 0.65 0.68 0.66 0.69
Long-Term Debt to Equity
0.33 0.38 0.43 0.43 0.39 0.45 0.49 0.46 0.52 0.50 0.51
Financial Leverage
0.27 0.36 0.38 0.39 0.34 0.43 0.48 0.48 0.44 0.51 0.55
Leverage Ratio
1.95 1.97 1.97 1.98 2.00 2.05 2.09 2.09 2.11 2.12 2.16
Compound Leverage Factor
1.88 1.91 1.91 1.92 1.95 1.99 2.03 2.03 2.04 2.07 2.11
Debt to Total Capital
32.04% 33.56% 35.24% 35.41% 35.38% 37.72% 39.33% 39.27% 40.45% 39.63% 40.81%
Short-Term Debt to Total Capital
9.88% 8.41% 7.51% 7.61% 10.28% 9.93% 9.44% 11.11% 9.45% 9.72% 10.69%
Long-Term Debt to Total Capital
22.16% 25.15% 27.72% 27.80% 25.11% 27.79% 29.89% 28.17% 31.00% 29.90% 30.12%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.27% 2.31% 2.25% 2.27% 2.28% 2.26% 2.23% 2.23% 2.24% 2.30% 2.26%
Common Equity to Total Capital
65.69% 64.13% 62.52% 62.31% 62.33% 60.03% 58.44% 58.50% 57.31% 58.07% 56.93%
Debt to EBITDA
1.61 1.67 1.74 1.80 1.72 1.89 2.02 1.98 2.09 1.99 2.09
Net Debt to EBITDA
1.04 1.27 1.37 1.38 1.16 1.47 1.65 1.63 1.54 1.69 1.72
Long-Term Debt to EBITDA
1.12 1.25 1.37 1.41 1.22 1.39 1.54 1.42 1.60 1.50 1.54
Debt to NOPAT
3.12 3.21 3.35 3.45 3.27 3.59 3.83 3.64 3.90 3.70 3.85
Net Debt to NOPAT
2.02 2.45 2.63 2.65 2.21 2.79 3.12 3.00 2.87 3.14 3.17
Long-Term Debt to NOPAT
2.16 2.41 2.64 2.71 2.32 2.64 2.91 2.61 2.99 2.79 2.84
Altman Z-Score
3.62 4.06 3.86 4.03 3.74 3.88 3.71 3.76 3.39 3.91 3.98
Noncontrolling Interest Sharing Ratio
3.31% 3.39% 3.35% 3.43% 3.44% 3.55% 3.57% 3.59% 3.65% 3.72% 3.75%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.80 0.91 0.95 0.96 0.89 0.94 0.93 0.82 0.88 0.83 0.88
Quick Ratio
0.60 0.69 0.71 0.72 0.65 0.71 0.68 0.61 0.66 0.60 0.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-537 1,080 609 -1,749 1,218 -694 -2,898 -1,882 -3,993 -2,518 -683
Operating Cash Flow to CapEx
236.92% 186.45% 170.26% 256.19% 224.72% 170.16% 175.90% 231.03% 207.82% 166.92% 157.93%
Free Cash Flow to Firm to Interest Expense
-7.57 16.61 8.70 -25.71 22.99 -11.57 -43.25 -29.41 -62.39 -40.61 -11.20
Operating Cash Flow to Interest Expense
38.41 30.06 27.56 40.16 53.00 36.02 33.00 46.06 47.34 36.13 37.23
Operating Cash Flow Less CapEx to Interest Expense
22.20 13.94 11.37 24.49 29.42 14.85 14.24 26.13 24.56 14.48 13.66
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.41 0.41 0.41 0.41 0.41 0.41 0.40 0.40 0.41 0.41 0.41
Accounts Receivable Turnover
7.08 6.71 6.70 6.91 7.07 6.63 6.50 6.57 7.09 6.75 6.53
Inventory Turnover
8.55 8.32 8.25 8.29 8.44 8.37 8.13 8.14 8.69 8.74 8.63
Fixed Asset Turnover
1.37 1.36 1.36 1.35 1.34 1.32 1.29 1.27 1.28 1.28 1.26
Accounts Payable Turnover
5.82 5.93 5.90 6.17 6.20 6.41 6.29 6.25 6.54 6.96 6.74
Days Sales Outstanding (DSO)
51.53 54.38 54.49 52.85 51.65 55.05 56.16 55.57 51.49 54.09 55.92
Days Inventory Outstanding (DIO)
42.70 43.88 44.25 44.05 43.23 43.63 44.89 44.82 41.99 41.76 42.30
Days Payable Outstanding (DPO)
62.76 61.54 61.88 59.18 58.84 56.95 58.05 58.39 55.80 52.47 54.12
Cash Conversion Cycle (CCC)
31.48 36.72 36.85 37.72 36.04 41.73 43.00 42.00 37.67 43.38 44.10
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
53,614 55,700 56,443 57,678 54,131 58,066 61,120 61,502 59,659 62,450 63,745
Invested Capital Turnover
0.63 0.59 0.59 0.59 0.61 0.58 0.57 0.56 0.60 0.58 0.57
Increase / (Decrease) in Invested Capital
2,099 549 1,062 3,331 517 2,366 4,677 3,824 5,528 4,384 2,625
Enterprise Value (EV)
213,594 245,391 234,229 253,197 222,092 249,204 253,517 256,662 231,266 267,878 280,066
Market Capitalization
199,700 228,520 215,965 234,692 206,053 229,170 230,912 233,776 209,852 243,994 255,402
Book Value per Share
$81.92 $80.57 $79.43 $82.04 $80.00 $80.42 $81.72 $82.35 $81.90 $83.23 $84.48
Tangible Book Value per Share
$1.18 $1.12 ($0.08) ($0.10) $1.73 ($0.08) ($2.93) ($2.44) ($3.33) ($2.13) ($0.89)
Total Capital
60,468 60,548 61,069 62,865 61,111 63,360 65,906 66,011 66,730 66,409 68,643
Total Debt
19,373 20,319 21,518 22,262 21,623 23,897 25,920 25,925 26,989 26,317 28,013
Total Long-Term Debt
13,397 15,227 16,931 17,475 15,343 17,608 19,701 18,592 20,683 19,859 20,678
Net Debt
12,519 15,471 16,892 17,075 14,643 18,603 21,134 21,416 19,918 22,358 23,115
Capital Expenditures (CapEx)
1,151 1,048 1,133 1,066 1,250 1,270 1,257 1,276 1,458 1,342 1,438
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,785 -1,043 -700 -989 -169 107 346 -37 -623 -141 486
Debt-free Net Working Capital (DFNWC)
2,879 3,805 3,926 4,198 4,681 5,401 5,132 4,472 4,433 3,818 5,384
Net Working Capital (NWC)
-3,097 -1,287 -661 -589 -1,599 -888 -1,087 -2,861 -1,873 -2,640 -1,951
Net Nonoperating Expense (NNE)
-14 -36 -29 -21 -34 -35 -27 -30 -38 -34 -30
Net Nonoperating Obligations (NNO)
12,519 15,471 16,892 17,075 14,643 18,603 21,134 21,416 19,918 22,358 23,115
Total Depreciation and Amortization (D&A)
949 949 958 960 913 910 942 961 950 951 963
Debt-free, Cash-free Net Working Capital to Revenue
-5.43% -3.18% -2.13% -2.99% -0.51% 0.32% 1.04% -0.11% -1.83% -0.41% 1.37%
Debt-free Net Working Capital to Revenue
8.76% 11.61% 11.96% 12.71% 14.18% 16.36% 15.44% 13.35% 13.04% 11.02% 15.19%
Net Working Capital to Revenue
-9.43% -3.93% -2.01% -1.78% -4.84% -2.69% -3.27% -8.54% -5.51% -7.62% -5.50%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $3.38 $0.00 $0.00 $0.00 $0.00 $0.00 $4.11 $0.00 $4.00 $4.17
Adjusted Weighted Average Basic Shares Outstanding
488.19M 481.95M 479.97M 477.66M 478.77M 473.30M 470.87M 468.80M 469.49M 464.05M 462.53M
Adjusted Diluted Earnings per Share
$3.15 $3.35 $3.44 $3.22 $3.61 $3.51 $3.73 $4.09 $3.28 $3.98 $4.15
Adjusted Weighted Average Diluted Shares Outstanding
492.29M 485.59M 483.18M 480.90M 482.09M 476.26M 473.57M 471.51M 472.20M 466.32M 464.52M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
481.58M 480.68M 477.50M 476.16M 472.91M 471.29M 468.91M 466.95M 463.39M 462.60M 460.98M
Normalized Net Operating Profit after Tax (NOPAT)
1,560 1,629 1,671 1,692 1,735 1,714 1,779 1,933 1,710 1,866 1,942
Normalized NOPAT Margin
18.79% 20.11% 20.21% 20.25% 20.95% 21.13% 20.94% 22.43% 19.51% 21.25% 20.91%
Pre Tax Income Margin
24.04% 25.68% 26.16% 24.69% 27.32% 26.87% 27.62% 27.39% 22.95% 27.68% 27.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
29.11 33.00 31.90 31.34 43.70 37.33 36.01 37.88 32.42 40.21 42.74
NOPAT to Interest Expense
21.99 25.06 23.87 23.27 32.74 27.87 26.55 30.34 23.99 30.10 31.84
EBIT Less CapEx to Interest Expense
12.90 16.88 15.71 15.66 20.11 16.17 17.25 17.94 9.64 18.56 19.16
NOPAT Less CapEx to Interest Expense
5.78 8.93 7.69 7.59 9.16 6.70 7.79 10.40 1.21 8.45 8.26
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
39.14% 39.17% 39.28% 39.91% 39.41% 39.74% 39.70% 38.21% 39.83% 39.22% 38.80%
Augmented Payout Ratio
101.56% 103.32% 110.70% 103.81% 105.94% 106.89% 101.03% 100.87% 105.02% 98.48% 93.50%

Financials Breakdown Chart

Key Financial Trends

Linde’s latest financial statements show a business with improving operating performance, although higher investment spending and debt usage are important risks for shareholders to monitor. The company’s Q2 2026 results also include restated and calculated historical figures, and some cash-flow entries appear to reflect year-to-date reporting rather than strictly quarterly activity. Comparisons should therefore be viewed as directional.

Revenue and profitability are trending higher. Q2 2026 revenue rose to $9.29 billion, up from $8.50 billion in Q2 2025 and $8.27 billion in Q2 2024. Operating income increased to $2.55 billion from $2.18 billion a year earlier. The operating margin expanded to approximately 27.5%, compared with 26.4% in Q2 2025 and 26.4% in Q2 2024. This suggests Linde is generating stronger profits from each dollar of sales.

Net income attributable to common shareholders increased to $1.93 billion in Q2 2026, compared with $1.86 billion in Q1 2026, $1.77 billion in Q2 2025 and $1.66 billion in Q2 2024. Diluted earnings per share rose to $4.15 from $3.73 in Q2 2025. The improvement in EPS was aided by both higher earnings and a reduction in diluted weighted-average shares to 464.5 million from 473.6 million a year earlier.

  • Strong recent revenue growth: Q2 2026 revenue increased approximately 9.3% year over year, while Q1 2026 revenue grew about 8.3% year over year.
  • Operating margin expansion: Q2 2026 operating income grew faster than revenue, pushing the operating margin to roughly 27.5%.
  • Higher earnings and EPS: Q2 2026 net income attributable to common shareholders rose to $1.93 billion, while diluted EPS increased to $4.15 from $3.73 in Q2 2025.
  • Share repurchases remain meaningful: Linde repurchased $871 million of common equity in Q2 2026 and $807 million in Q1 2026, helping reduce the share count and support per-share results.
  • Substantial operating cash generation: Continuing operating cash flow was $2.29 billion in Q2 2026 and $2.23 billion in Q1 2026, providing funding for capital expenditures, dividends and buybacks.
  • Capital investment is growing the asset base: Net property, plant and equipment increased to $29.17 billion in Q2 2026 from $24.42 billion in Q1 2024, indicating continued investment in production capacity and infrastructure.
  • Shareholder distributions are substantial: Linde paid $738 million in dividends and repurchased $871 million of stock during Q2 2026. These distributions support shareholder returns but also consume cash that could otherwise reduce debt.
  • Cash balances recovered in Q2: Cash and equivalents increased to $4.90 billion at June 30, 2026, from $3.96 billion at March 31, 2026, helped by a $2.01 billion debt issuance and positive operating cash flow.
  • Debt has increased materially: Short- and long-term debt totaled approximately $28.1 billion in Q2 2026, up from roughly $21.6 billion at the end of 2024. The increase raises interest-rate and refinancing risks.
  • Working capital and liquidity warrant monitoring: Current liabilities of $16.13 billion exceeded current assets of $14.18 billion in Q2 2026, producing a current ratio below 1.0. Accounts receivable also increased to $5.63 billion, while operating cash flow continued to be reduced by sizable working-capital uses.

Investment spending is another key consideration. Linde spent $1.44 billion on property, plant and equipment in Q2 2026, up from $1.26 billion in Q2 2025. Based on continuing operating cash flow less capital expenditures, approximate quarterly free cash flow was about $853 million in Q2 2026. That amount was not enough to fully cover dividends and share repurchases, contributing to the company’s reliance on debt issuance and existing cash reserves.

The balance sheet has expanded, with total assets reaching $88.35 billion in Q2 2026 versus $80.15 billion at the end of 2024. However, goodwill and intangible assets totaled approximately $39.5 billion, or about 45% of total assets. This sizable level of acquired intangible value makes future impairment charges a risk if business conditions weaken.

Overall, Linde’s recent statements point to improving sales, expanding operating margins and rising EPS. The primary offset is that capital allocation has become more debt-dependent: investment spending, dividends and buybacks together are placing pressure on internally generated cash. Investors should watch whether operating cash flow continues to grow fast enough to fund these priorities while stabilizing leverage.

09/08/26 09:39 AM ETAI Generated. May Contain Errors.

Linde Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Linde's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Linde's net income appears to be on an upward trend, with a most recent value of $7.06 billion in 2025, rising from $1.54 billion in 2016. The previous period was $6.74 billion in 2024. See Linde's forecast for analyst expectations on what's next for the company.

Linde's total operating income in 2025 was $8.92 billion, based on the following breakdown:
  • Total Gross Profit: $16.60 billion
  • Total Operating Expenses: $7.67 billion

Over the last 9 years, Linde's total revenue changed from $10.53 billion in 2016 to $33.99 billion in 2025, a change of 222.6%.

Linde's total liabilities were at $47.08 billion at the end of 2025, a 15.8% increase from 2024, and a 238.3% increase since 2017.

In the past 8 years, Linde's cash and equivalents has ranged from $617 million in 2017 to $5.44 billion in 2022, and is currently $5.06 billion as of their latest financial filing in 2025.

Over the last 9 years, Linde's book value per share changed from 0.00 in 2016 to 81.90 in 2025, a change of 8,190.4%.



Financial statements for NASDAQ:LIN last updated on 7/31/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners